One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood-2019-122902
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 5 |
Affiliation: Duke Medical Center, Karyopharm Therapeutics (United States), Hôpital Maisonneuve-Rosemont, University of California, Los Angeles, University of Nebraska Medical Center, Vancouver General Hospital, CancerCare Manitoba, Princess Margaret Cancer Centre, UW Carbone Cancer Center, University of Wisconsin–Madison, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Royal Victoria Regional Health Centre, University of North Carolina at Chapel Hill, University of RochesterA Phase 1b/2 Study of Selinexor, Carfilzomib, and Dexamethasone (SKd) in Relapsed/ Refractory Multiple Myeloma (RRMM)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
